سعر اوكسازوليد 100مجم/5مل معلق 150 مل 2026

Oxazolid 100 mg/5 ml powder for oral suspension 150 ml: linezolid 100 mg/5 ml powder for oral suspension by Averroes Pharma (Egypt) > Pharma Cure Pharmaceuticals; pack: 1 bottle, 150 ml (after reconstitution). Antibiotic (Gram-positive infections).

• Nosocomial pneumonia and community-acquired pneumonia caused by susceptible Gram-positive bacteria.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Complicated skin and skin structure infections (including diabetic foot infections without osteomyelitis) and uncomplicated skin infections.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)
• Vancomycin-resistant Enterococcus faecium infections.Population: Adults and childrenDailyMed (U.S. National Library of Medicine)

• Most common (> 5%): diarrhoea, vomiting, headache, nausea and anaemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to linezolid or any product component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Patients taking any MAO-A or MAO-B inhibitor or within two weeks of taking one.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Myelosuppression (anaemia, leukopenia, pancytopenia, thrombocytopenia); peripheral and optic neuropathy; serotonin syndrome with serotonergic agents; lactic acidosis; hypoglycaemia; pressor response with adrenergic agents; Clostridioides difficile-associated diarrhoea.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• MAO inhibitorsContraindicated (including within 2 weeks).DailyMed (U.S. National Library of Medicine)
• Serotonergic drugs (SSRIs, other antidepressants, opioids)Risk of serotonin syndrome.DailyMed (U.S. National Library of Medicine)
• Adrenergic agents (pseudoephedrine, phenylpropanolamine)Reversible enhancement of pressor response.DailyMed (U.S. National Library of Medicine)

• Published and post-marketing case reports have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; embryo-fetal lethality in mice at 6.5 times human exposure.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Present in breast milk (infant dose about 6-9% of the therapeutic infant dose); monitor breastfed infants for diarrhoea and vomiting.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Linezolid: Binds the 23S ribosomal RNA of the bacterial 50S subunit and prevents formation of a functional 70S initiation complex, inhibiting protein synthesis; also a reversible nonselective MAO inhibitor (US ZYVOX label).